BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26518164)

  • 21. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
    Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
    Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of genetically engineered mesenchymal stem cells with Apoptin on hepatoma cells in vitro and in vivo.
    Zhang J; Hou L; Wu X; Zhao D; Wang Z; Hu H; Fu Y; He J
    Mol Cell Biochem; 2016 May; 416(1-2):193-203. PubMed ID: 27142531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow mesenchymal stem cells suppress ascitogenous hepatoma progression in BALB/c mouse through reducing myeloid-derived suppressor cells.
    Su X; Zhang L; Ye J; Yang L; Li Y; Wang Y
    Biomed Mater Eng; 2015; 25(1 Suppl):167-77. PubMed ID: 25538067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment for Hepatocellular Carcinoma Is Enhanced When Norcantharidin Is Encapsulated in Exosomes Derived from Bone Marrow Mesenchymal Stem Cells.
    Liang L; Zhao L; Wang Y; Wang Y
    Mol Pharm; 2021 Mar; 18(3):1003-1013. PubMed ID: 33527831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of bone marrow-derived mesenchymal stromal cells on hepatoma.
    Abd-Allah SH; Shalaby SM; El-Shal AS; Elkader EA; Hussein S; Emam E; Mazen NF; El Kateb M; Atfy M
    Cytotherapy; 2014 Sep; 16(9):1197-206. PubMed ID: 24985939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
    Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
    Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simvastatin induces growth inhibition and apoptosis in HepG2 and Huh7 hepatocellular carcinoma cells via upregulation of Notch1 expression.
    Huang X; Ma J; Xu J; Su Q; Zhao J
    Mol Med Rep; 2015 Mar; 11(3):2334-40. PubMed ID: 25412322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Niemann-Pick type C2 protein regulates liver cancer progression via modulating ERK1/2 pathway: Clinicopathological correlations and therapeutical implications.
    Liao YJ; Fang CC; Yen CH; Hsu SM; Wang CK; Huang SF; Liang YC; Lin YY; Chu YT; Arthur Chen YM
    Int J Cancer; 2015 Sep; 137(6):1341-51. PubMed ID: 25754535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth.
    Bruno S; Collino F; Deregibus MC; Grange C; Tetta C; Camussi G
    Stem Cells Dev; 2013 Mar; 22(5):758-71. PubMed ID: 23034046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of transforming growth factor β-1 infected human bone marrow mesenchymal stem cells on high- and low-metastatic potential hepatocellular carcinoma.
    Li T; Zhao S; Song B; Wei Z; Lu G; Zhou J; Huo T
    Eur J Med Res; 2015 May; 20(1):56. PubMed ID: 26003220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.
    Cai X; Hu X; Cai B; Wang Q; Li Y; Tan X; Hu H; Chen X; Huang J; Cheng J; Jing X
    Oncol Rep; 2013 Nov; 30(5):2449-57. PubMed ID: 24008375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization and Validation of Hepatocellular Carcinoma (HCC) Xenograft tumor as a Suitable Liver Cancer Model for Preclinical Mesenchymal Stem Cell Studies.
    Hajighasemlou S; Pakzad S; Ai J; Muhammadnejad S; Mirmoghtadaei M; Hosseinzadeh F; Gharibzadeh S; Kamali A; Ahmadi A; Verdi J
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1627-1631. PubMed ID: 29936790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenovirus and retrovirus mediated interferon alpha gene transfer into CD34+ cells maintains regeneration capacity and enhances adhesion molecules in K562 cells.
    Seiter K; Kancherla R; Yang L; Quan S; Farley TJ; Abraham NG; Ahmed T
    J Investig Med; 1999 Sep; 47(8):414-24. PubMed ID: 10510594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice.
    Gao Y; Yao A; Zhang W; Lu S; Yu Y; Deng L; Yin A; Xia Y; Sun B; Wang X
    Oncogene; 2010 May; 29(19):2784-94. PubMed ID: 20190814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the genes chemosensitizing hepatocellular carcinoma cells to interferon-α/5-fluorouracil and their clinical significance.
    Sakabe T; Tsuchiya H; Kanki K; Azumi J; Gonda K; Mizuta Y; Yamada D; Wada H; Shomori K; Nagano H; Shiota G
    PLoS One; 2013; 8(2):e56197. PubMed ID: 23457527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy.
    Shen S; Sun CY; Du XJ; Li HJ; Liu Y; Xia JX; Zhu YH; Wang J
    Biomaterials; 2015 Nov; 70():71-83. PubMed ID: 26302232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear α1-antichymotrypsin promotes chromatin condensation and inhibits proliferation of human hepatocellular carcinoma cells.
    Santamaria M; Pardo-Saganta A; Alvarez-Asiain L; Di Scala M; Qian C; Prieto J; Avila MA
    Gastroenterology; 2013 Apr; 144(4):818-828.e4. PubMed ID: 23295442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
    Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
    Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.